melanoma potent lethal skin cancer wide thought immunogen natur much focus cellmedi immune response limit knowledge exist role mater b cell describe approach include cells lisa value img antibody human periphery blood observe signifies increase patient n primary metastatic compare health volume p interesting detect reduce advance disease stage patient cohort overall patientderiv cell culture control product antibody recon lastly melanomaspecif monoclonal select studi effect kill vitro via antibodymedi cellular cytotox data demons present system response reduce progress ad previous report tumorreact serum suggest merit future work lucid clinic elev active humor 